These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

265 related items for PubMed ID: 17595476

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Results 28 months following transpupillary thermotherapy for classic and occult choroidal neovascularization in patients with age-related macular degeneration.
    Newsom RS, McAlister JC, Saeed M, El-Ghonemy K, McHugh JD.
    Ophthalmic Surg Lasers Imaging; 2005; 36(2):94-102. PubMed ID: 15792308
    [Abstract] [Full Text] [Related]

  • 23. Photodynamic therapy for age-related macular degeneration treatment: epidemiological and clinical analysis of a long-term study.
    Mataix J, Desco MC, Palacios E, Garcia-Pous M, Navea A.
    Ophthalmic Surg Lasers Imaging; 2009; 40(3):277-84. PubMed ID: 19485292
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. 12-month retrospective study and review of photodynamic therapy with verteporfin for subfoveal choroidal neovascularization in age-related macular degeneration.
    Incorvaia C, Campa C, Parmeggiani F, Menzione M, D'Angelo S, Della Corte M, Rinaldi M, Romano M, Dell'omo R, Costagliola C.
    Retina; 2008 Feb; 28(2):289-97. PubMed ID: 18301052
    [Abstract] [Full Text] [Related]

  • 26. A preliminary study of photodynamic therapy using verteporfin for choroidal neovascularization in pathologic myopia, ocular histoplasmosis syndrome, angioid streaks, and idiopathic causes.
    Sickenberg M, Schmidt-Erfurth U, Miller JW, Pournaras CJ, Zografos L, Piguet B, Donati G, Laqua H, Barbazetto I, Gragoudas ES, Lane AM, Birngruber R, van den Bergh H, Strong HA, Manjuris U, Gray T, Fsadni M, Bressler NM.
    Arch Ophthalmol; 2000 Mar; 118(3):327-36. PubMed ID: 10721954
    [Abstract] [Full Text] [Related]

  • 27. Vision-related function after low-dose transpupillary thermotherapy versus photodynamic therapy for neovascular age-related macular degeneration.
    Odergren A, Algvere PV, Seregard S, Libert C, Kvanta A.
    Acta Ophthalmol; 2010 Jun; 88(4):426-30. PubMed ID: 20597872
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Japanese age-related macular degeneration trial: 1-year results of photodynamic therapy with verteporfin in Japanese patients with subfoveal choroidal neovascularization secondary to age-related macular degeneration.
    Japanese Age-Related Macular Degeneration Tial (JAT) Study Group.
    Am J Ophthalmol; 2003 Dec; 136(6):1049-61. PubMed ID: 14644215
    [Abstract] [Full Text] [Related]

  • 30. [Photodynamic therapy in age-related macular degeneration--results of one year observation].
    Wykrota H, Gierek-Łapińska A.
    Klin Oczna; 2002 Dec; 104(3-4):239-43. PubMed ID: 12608309
    [Abstract] [Full Text] [Related]

  • 31. [Clinical trial of verteporfin photodynamic therapy in Chinese age-related macular degeneration with subfoveal predominant choroidal neovascularization patients].
    Chen YX, Ge J, Yan M, Jin CJ, Zhang MX, Dong FT, Lu F, Zhang CF, Zhao JL.
    Zhonghua Yan Ke Za Zhi; 2007 Mar; 43(3):198-205. PubMed ID: 17605900
    [Abstract] [Full Text] [Related]

  • 32. Treatment of juxtafoveal choroidal neovascularization with photodynamic therapy using verteporfin in eyes with age-related macular degeneration.
    Hariprasad SM, Shah GK.
    Ophthalmic Surg Lasers Imaging; 2005 Mar; 36(3):258-60. PubMed ID: 15957487
    [Abstract] [Full Text] [Related]

  • 33. Occult with no classic subfoveal choroidal neovascular lesions in age-related macular degeneration: clinically relevant natural history information in larger lesions with good vision from the Verteporfin in Photodynamic Therapy (VIP) Trial: VIP Report No. 4.
    Pieramici DJ, Bressler SB, Koester JM, Bressler NM.
    Arch Ophthalmol; 2006 May; 124(5):660-4. PubMed ID: 16682587
    [Abstract] [Full Text] [Related]

  • 34. Photodynamic therapy with verteporfin for peripapillary choroidal neovascularization.
    Rosenblatt BJ, Shah GK, Blinder K.
    Retina; 2005 Jan; 25(1):33-7. PubMed ID: 15655438
    [Abstract] [Full Text] [Related]

  • 35. Verteporfin therapy and intravitreal bevacizumab combined and alone in choroidal neovascularization due to age-related macular degeneration.
    Lazic R, Gabric N.
    Ophthalmology; 2007 Jun; 114(6):1179-85. PubMed ID: 17544776
    [Abstract] [Full Text] [Related]

  • 36. [Transpupillary thermotherapy and age-related macular degeneration].
    Desmettre T, Meunier I, Maurage CA, Mordon S.
    J Fr Ophtalmol; 2004 Nov; 27(9 Pt 2):3S57-64. PubMed ID: 15602407
    [Abstract] [Full Text] [Related]

  • 37. Verteporfin therapy combined with intravitreal triamcinolone in all types of choroidal neovascularization due to age-related macular degeneration.
    Augustin AJ, Schmidt-Erfurth U.
    Ophthalmology; 2006 Jan; 113(1):14-22. PubMed ID: 16360209
    [Abstract] [Full Text] [Related]

  • 38. Combined photodynamic therapy with verteporfin and intravitreal bevacizumab for choroidal neovascularization in age-related macular degeneration.
    Dhalla MS, Shah GK, Blinder KJ, Ryan EH, Mittra RA, Tewari A.
    Retina; 2006 Jan; 26(9):988-93. PubMed ID: 17151484
    [Abstract] [Full Text] [Related]

  • 39. Short-term reaction of choroidal neovascularization and choriocapillaris to photodynamic therapy in age-related macular degeneration.
    Eter N, Vogel A, Inhetvin-Hutter C, Spitznas M.
    Eur J Ophthalmol; 2003 Oct; 13(8):687-92. PubMed ID: 14620172
    [Abstract] [Full Text] [Related]

  • 40. Ocular haemodynamic changes after single treatment with photodynamic therapy assessed with non-invasive techniques.
    Maar N, Pemp B, Kircher K, Luksch A, Weigert G, Polska E, Tittl M, Stur M, Schmetterer L.
    Acta Ophthalmol; 2009 Sep; 87(6):631-7. PubMed ID: 19416111
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.